UpFront
Advertisement

As global pharma realigns, Vikram Punia sees India–Russia–EAEU axis emerging as
Vikram Punia underscores the growing India–Russia–EAEU pharmaceutical axis as a strategic opportunity for Indian firms entering expanding Eurasian healthcare markets
Advertisement
Advertisement
...
Explore More Categories
- Home /
- UpFront
Advertisement
Advertisement
Advertisement